Sign inGet started

OrbiMed Capital GP IX LLC

Insider CIK 1920574 · STTK Director · NONE Director · BRVE Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BRVE Braveheart Bio, Inc. C Conversion deriv2026-08-072026-08-1140,000,000— $00SEC↗
BRVE Braveheart Bio, Inc. P Buy2026-08-072026-08-11273,333$18.00 $4.92M273,333SEC↗
BRVE Braveheart Bio, Inc. C Conversion2026-08-072026-08-119,132,420— $010,235,159SEC↗
BRVE Braveheart Bio, Inc. P Buy2026-08-072026-08-111,666,667$18.00 $30.00M11,901,826SEC↗
BRVE Braveheart Bio, Inc. C Conversion deriv2026-08-072026-08-1140,000,000— $00SEC↗
BRVE Braveheart Bio, Inc. P Buy2026-08-072026-08-11273,333$18.00 $4.92M273,333SEC↗
BRVE Braveheart Bio, Inc. P Buy2026-08-072026-08-111,666,667$18.00 $30.00M11,901,826SEC↗
BRVE Braveheart Bio, Inc. C Conversion2026-08-072026-08-119,132,420— —10,235,159SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2026-06-112026-06-15208,333— $05,303,908SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2026-06-112026-06-151,041,667— $026,519,541SEC↗
STTK Shattuck Labs, Inc. C Conversion deriv2026-06-082026-06-0915,366,490— $025,477,874SEC↗
STTK Shattuck Labs, Inc. C Conversion deriv2026-06-082026-06-093,073,298— $05,095,575SEC↗
STTK Shattuck Labs, Inc. C Conversion deriv2026-06-082026-06-0915,366,490— $00SEC↗
STTK Shattuck Labs, Inc. C Conversion deriv2026-06-082026-06-093,073,298— $00SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2025-08-252025-09-0215,366,490— $015,366,490SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2025-08-252025-09-023,073,298— $03,073,298SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2025-08-252025-09-0210,111,384— $010,111,384SEC↗
STTK Shattuck Labs, Inc. P Buy deriv2025-08-252025-09-022,022,277— $02,022,277SEC↗
STTK Shattuck Labs, Inc. P Buy2025-08-252025-09-021,051,021$0.87 $914.4K1,051,021SEC↗
STTK Shattuck Labs, Inc. P Buy2025-08-252025-09-025,255,106$0.87 $4.57M5,255,106SEC↗
NONE Lomond Therapeutics Holdin C Conversion deriv2024-11-012024-11-05215,146— $00SEC↗
NONE Lomond Therapeutics Holdin C Conversion deriv2024-11-012024-11-05389,078— $00SEC↗
NONE Lomond Therapeutics Holdin C Conversion deriv2024-11-012024-11-05230,753— $00SEC↗
NONE Lomond Therapeutics Holdin C Conversion deriv2024-11-012024-11-0574,613— $00SEC↗
NONE Lomond Therapeutics Holdin C Conversion deriv2024-11-012024-11-05323,916— $00SEC↗
NONE Lomond Therapeutics Holdin C Conversion2024-11-012024-11-05215,146$3.20 $688.5K539,062SEC↗
NONE Lomond Therapeutics Holdin C Conversion2024-11-012024-11-05230,753$3.60 $830.7K1,158,893SEC↗
NONE Lomond Therapeutics Holdin C Conversion2024-11-012024-11-0574,613$3.60 $268.6K1,233,506SEC↗
NONE Lomond Therapeutics Holdin A Award2024-11-012024-11-05808,894$4.00 $3.24M2,042,400SEC↗
NONE Lomond Therapeutics Holdin A Award2024-11-012024-11-05479,736$4.00 $1.92M2,522,136SEC↗
NONE Lomond Therapeutics Holdin A Award2024-11-012024-11-05155,120$4.00 $620.5K2,677,256SEC↗
NONE Lomond Therapeutics Holdin C Conversion2024-11-012024-11-05389,078$3.60 $1.40M928,140SEC↗
NONE Lomond Therapeutics Holdin C Conversion2024-11-012024-11-05323,916$3.20 $1.04M323,916SEC↗